Sard Verbinnen and Co.

Aegerion Pharmaceuticals Announces Additional Lomitapide (AEGR-733) Phase III Data Demonstrates Significant Lowering of LDL Cholesterol with Promising Safety Profile.
Biotech Week; 12/2/2009; 1550 words; ...Christine Pellizzari, Senior Vice President, General Counsel and Secretary (908) 707-2100 Media Contact: Sard Verbinnen & Co. Jim Barron/Lesley Bogdanow/Nick Lawler (212) 687-8080 Keywords: Adverse Drug Effect, Adverse Drug Event...

Cowen Group Announces Formation of REIT Research Team.
PR Newswire; 11/16/2009; 964 words; ...financial centers around the world. CONTACT: Media, Dan Gagnier, or Kara Findlay, or Chris Kittredge, all of Sard Verbinnen & Co, +1-212-687-8080; or Jean Calleja, +1-646-562-1888; or Investors, Chris White, +1-646...

Transom.
PR Week (US); 11/13/2009; 833 words; ...first three quarters. The firm represented Pfizer and Roche in those deals. Rounding out the top three were Sard Verbinnen & Co. and Joele Frank, Wilkinson Brimmer Katcher. FD took the top position in terms of volume, working on 102...

NIRI Elects Brad Wilks New Board Chairman.
Investment Business Weekly; 10/18/2009; 978 words; ...Board of Directors. Wilks is Managing Director of Sard Verbinnen & Co, a leading provider of strategic corporate, financial...senior executive changes, etc. Prior to joining Sard Verbinnen, Wilks was managing director and head of the Chicago...

NIRI Elects Brad Wilks New Board Chairman
Manufacturing Close-Up; 10/1/2009; 666 words; ...Board of Directors. Wilks is Managing Director of Sard Verbinnen & Co, a provider of strategic corporate, financial and...senior executive changes, etc. Prior to joining Sard Verbinnen, Wilks was managing director and head of the Chicago...